Press Release: The Trout Group : Motif Bio to participate in panel discussion at upcoming Cantor Antibiotics Summit
Motif Bio plc (AIM: MTFB) (NASDAQ: MTFB), a clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced today that the Company will participate in the following event:
Read full article »
Trout is an investor relation and strategic advisory firm that provides targeting, outreach and market intelligence services to medical and life science sectors.
Read more